Only a Few Public Biotechs are Profitable, but There are More of Them Today pos NI drug biotechs

Public Policy

Gene Patents, Angelina Jolie, and Reality
By Dr. Hans Sauer, J.D., Deputy General Counsel for Intellectual Property, Biotechnology Industry Organization Angelina Jolie...

Read More >
Business and Investments

BIO Convention Post-Con, Plus a Look Ahead
Last month, the biopharma community gathered for the industry's largest event, the BIO International Convention. We hope the event...

Read More >
Corporate

Twenty Years & Counting: Welcome to Chicago!
Welcome to the 2013 BIO International Convention. It is hard to believe, but this year BIO reaches a significant milestone as we c...

Read More >
Environmental & Industrial

Roundtable Discussion Highlights Innovation, Commercial Reality for Renewable Chemical Products
Last week BIO brought together representatives from five renewable chemical companies that will be speaking at BIO’s World Congr...

Read More >
Events

Five Countries, One Goal: Collaboration with Global Impact in the Life Sciences Industry
During the 2013 BIO International Convention, the Massachusetts Life Sciences Center (MLSC) and regions from four other countrie...

Read More >
Food And Agriculture

Time Magazine Modifies the Endless Debate Over GM Crops
Bryan Walsh wrote for Time magazine about the so-called “obsession” surrounding genetically modified (GM) crops: "To enviro...

Read More >
Health

Act Now to Protect Public Health and Prepare for the Upcoming Flu Season
As many as 49,000 people die from the flu annually, depending on the season, and children and the elderly are the most vulnerable...

Read More >